Michael Lawrence Foster, M.D.

NPI 1588927719ActiveIndividual· Internal Medicine, Pulmonary Disease· Richardson, TX

Internal Medicine, Pulmonary Disease (M.D.) in Richardson, Texas, trained at University of Texas Medical School at Houston (class of 2012). Their prescriptions cost Medicare Part D more than their services did: $469,166 for 1,328 claims, against $251,939 paid for services in 2024. Glaxosmithkline, LLC. was the largest of 7 companies reporting payments in 2025, $217.30 in all, mostly food and beverage.

Overview

NPI	1588927719
Status	Active
Entity type	Individual
Credential	M.D.
Sole proprietor	No
NPI issued	Jun 22, 2012
Last updated in NPPES	Apr 8, 2021
Certified by provider	Apr 8, 2021

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Pulmonary Disease Primary	207RP1001X	Q4107	TX

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Pulmonary Disease (TX)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	595
Services billed	2,702 across 47 procedure codes
Paid by Medicare	$251,939

Part D prescriptions in 2024

Prescriptions (claims)	1,328 · 2,247 30-day fills
Patients	286
Total drug cost	$469,166
Generic share	50% of claims

Medicare sources and data years

Education and affiliations

Medical school	University of Texas Medical School at Houston
Graduation year	2012
Medicare specialty	Pulmonary Disease
Secondary specialties	Critical Care (Intensivists)
Telehealth	Offers telehealth